相关实验视频
Updated: Jun 11, 2025

04:44
Developing a Rat Model for Bipolar Disorder
Published on: May 2, 2025
222
双极性障碍患者需要知道的关于的信息
Robert M Post1, Janusz K Rybakowski2
1Bipolar Collaborative Network, Chevy Chase, MD 20815, USA.
Pharmaceuticals (Basel, Switzerland)
|September 28, 2024
概括
是对双相情感障碍 (BD) 的最佳一线治疗方法,但由于声誉不佳,其使用率很低. 教育患者关于的知识.
科学领域:
- 精神病学和药理学 精神病学和药理学
背景情况:
- 是双相情感障碍 (BD) 的黄金标准第一线治疗方法.
- 目前在BD患者中,的处方率显著低,特别是在美国.
- 患者和处方人员对的益处和风险的认识存在重大差距.
研究的目的:
- 倡导增加患者对在双相情感障碍治疗中的疗效和特征的教育.
- 为了解决独特的治疗资产的低估和其副作用概况的高估.
- 提出的重塑品牌和重命名战略,以改善其知觉和临床应用.
主要方法:
- 关于在双相情感障碍中的疗效和副作用概况的现有文献的综述.
- 分析导致采用率低的因素.
- 制定沟通战略,重塑的公众和专业形象.
主要成果:
- 对双相情感障碍具有独特的治疗优势,但这些优势往往被低估.
- 与实际临床数据相比,与相关的感知风险和副作用往往是夸张的.
- 负面的公众和专业声誉阻碍了适当和及时使用.
结论:
- 迫切需要提高患者和医生对对双相情感障碍的益处的理解.
- 修改围绕的叙述和术语对于改善其利用至关重要.
- 实施重塑品牌的倡议可以显著提高在BD治疗中的适当应用.
相关概念视频
Mania and Antimanic Drugs: Overview
139
Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as...
139
Bipolar Disorder
58
Bipolar disorder is a chronic mental health condition marked by significant mood fluctuations, including episodes of mania and depression. Elevated energy levels, heightened mood or irritability, impulsive behavior, reduced sleep needs, rapid speech, racing thoughts, inflated self-esteem, and distractibility characterize mania. Individuals with bipolar disorder often alternate between depressive and manic states, with periods of emotional stability lasting an average of six months to a year.
58
Drug Therapy
39
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
39
Psychosis: Goals of Pharmacotherapy
110
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
110
Electroconvulsive Therapy
28
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
28
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
1.3K
Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
1.3K

